News Detail
Ahmedabad, 21 Sept 2023: The CESTAT, Ahmedabad in Lyka Labs Limited vs C.C.E. & S.T.-SURAT-II [Exice Appeal No. 10218 of 2013 dated September 12, 2023] set aside the order passed by the Adjudicating Authority and held that, addition of non-activ......
View Details
Source : A2Z Taxcorp LLP
CESTAT Ahmedabad
Lyka Labs Limited vs C.C.E. & S.T.-SURAT-II
set aside the order
non-active ingredients
preservatives
Related News
- Zydus gets warning as FDA highlights glass contamination concerns and others (12-09-2024)
- MPIDC allotted land to 36 industries in Medical Devices Park, investment of 1.8k crore (12-09-2024)
- DCC asks states and UTs to ensure implementation of revised Schedule M (12-09-2024)
- NPPA fixes retail price of 62 new drugs, extends CP of knee implants (12-09-2024)
- US FDA Issues Revised Guidance On Controlling Nitrosamine Impurities In Pharmaceuticals (12-09-2024)
- Bharat Biotech collaborates with US-based Alopexx to develop antimicrobial vaccine (12-09-2024)
- DCGI suspends permission to Entod pharma's 'Presvu Eye Drops', company to challenge order in court (11-09-2024)
- Diagnostic kits for early detection of Alzheimer’s and cancer launched (11-09-2024)
- FDI equity inflow into pharma sector grows to $236 million in Q1FY25 (11-09-2024)
- Steroid Use Could Raise Diabetes Risk (11-09-2024)